Cytodyn Inc (CYDY)

[$5.95akadawson-m]

LET ME REMIND EVERYONE - directly from the President:

"The FDA requested that CytoDyn address five discreet items. Three have been submitted to the agency, and the other two should be submitted shortly. The FDA will then have 30 days to review the information and will hopefully lift the hold."

"Once that is taken care of, we plan to go out and raise financing to fund operations. Once the financing has been stabilized, we will bring people onboard with relevant biotech experience and expertise that can support our development goals, which include starting a NASH trial and continuing to invest in and advance our long-acting CCR5 molecule. A corporate rebranding campaign will also be implemented to put some of these issues in the past while creating a new face for the company."

"We will bring people onboard..." Hansen??